Local (216) 931-7000

Get Frank

Live Help

Ohio Bad Drugs/Medical Device Lawyers

Cleveland and Ohio Legal News and Analysis

Contact Attorney Frank Piscitelli and Get Justice. 
Call (216) 931-7000®

I’m Frank Piscitelli. I started my firm with one goal in mind–superior legal representation for the “little guy” against big, abusive insurance companies and corporations that hire an army of lawyers to stomp all over you. That won’t happen on my watch. They will have to stomp me first. I’ve made a career taking tough cases, often ones rejected by other law firms because they were “too hard”, “not worth enough” or because the other firm didn’t “believe it was a case”. I’ve taken those cases and recovered millions of dollars for hard-working people that just needed someone to fight for them. Representing people is hard work. You want a lawyer that will work tirelessly to get what you deserve. Not a lawyer promising to get you paid, and if he can’t settle your case, referring your case to a lawyer like me. I’m not looking to settle your case cheap and make a quick buck. I will fight for you and I’m not afraid to take your case to trial, if thats what it takes to get you the justice you deserve. So call me and lets talk about how I can help you.

Blog Category:
08/05/2014

Citizen Petition for Transvaginal Mesh Ban Has Been Rejected by FDA

Regulators at the U.S. Food and Drug Administration (FDA) have recently announced that they will not move forward with a transvaginal mesh ban, despite recent urgings from advocates at Public Citizen (a non-profit advocacy group for consumers). While the Public Citizen petition, dated August 25, 2011, had strongly encouraged the FDA to issue a transvaginal mesh ban in the U.S….


07/31/2014

Does FDA 510(k) Process for Medical Devices Do More Harm than Good? (Pt. 2)

Picking up from where we left off in Does FDA 510(k) Process for Medical Devices Do More Harm than Good? (Pt. 1), below we will continue our discussion of the FDA 510(k) process. While the first part of this blog focused on explaining what this process is and how it works, here, we will take a closer look at some…


07/23/2014

Does FDA 510(k) Process for Medical Devices Do More Harm than Good? (Pt. 1)

The public generally trusts that medical devices available in the U.S have undergone rigorous testing and screening by the regulators at the U.S. Food and Drug Administration (FDA) to ensure these medical devices are both safe and effective for their specified use. While this may be true in many cases, there is a significant – and widely used – loophole…


06/08/2014

Recent Victoza Study Highlights Links to Pancreatitis, Renews Urge for FDA Ban

The potential risks associated with the use of Victoza (liraglutide) have become the subject of renewed public attention, as a recently published study is shedding new light on the possible link between taking this type-2 diabetes drug and developing pancreatitis. Published in early June 2014, this Victoza study was led by researchers at Public Citizen, who specifically analyzed reports submitted…


04/19/2013

Ohio Bad Drug Attorney Discusses Bellweather Actos Trial

April 19, 2013 The first trial of more than 3,300 cases filed against Takeda Pharmaceutical Co. for the diabetes medication, Actos, is currently in jury deliberations. The case, filed in California, is captioned Jack Cooper vs. Takeda Pharmaceuticals. Takeda, a Japanese pharmaceutical company, denies the allegations that it failed to warn patients and prescribing doctors of the risks of Actos. According…


04/12/2013

Ohio Bad Drug Attorney Reports on 2nd Fosamax Femur Fracture Trial

April 12, 2013 The second Fosamax femur fracture trial began Tuesday in New Jersey. There are more than 3,300 pending cases which allege the bisphosphonate drug causes atypical femur fractures after long term use. The Plaintiff, Bernadette Glynn, took Fosamax for more than six years before suffering a femur fracture while bending over to pick something up. Her attorney, Paul…


03/13/2013

Ohio Drug Injury Lawyer Discusses Opening Statements In Bellweather Fosamax Fracture Trial

March 13, 2013 Atlantic City, New Jersey is the setting for the first Fosamax femur fracture trial. In the courtroom, lawyers for Christina Su, a retired systems analyst who took Fosamax for more than five years and suffered serious fractures, argued that Merck covered up 15 years of studies that indicate that taking the drug long-term puts women with osteoporosis at…


03/04/2013

Ohio Drug Injury Lawyer Advises that first Fosamax Femur Fracture Cases to be tried in New Jersey

March 4, 2013 The bellweather Fosamax femur fracture cases are scheduled to begin today in New Jersey Superior Court, Atlantic County Civil Courthouse. Su v. Merck will be heard by Judge Carol Higbee. It will be broadcast live on Courtroom View Network (CVN). The Fosamax Injury Attorneys at the Piscitelli Law Firm will be watching this case closely, and will keep…


03/01/2013

Ohio Drug Injury Attorney Reports on News of Amgen, Inc’s Discontinuation of Pediatric Studies of Sensipar i

March 1, 2013 FDA announced that it has stopped pediatric clinical studies of the parathyroid medication, Sensipar after the death of a 14 year old girl in the study. It is not known if the drug is linked to the death yet. Sensipar is used to lower the amount of calcium in the blood stream, caused by cancer, problems with the parathyroid gland,…


03/01/2013

Ohio Drug Injury Lawyer Notifies Potential Clients of Another Drug Recall, Vistide

March 1, 2013 The FDA announced that Gilead Sciences has issued a voluntary recall of Vistide, an intravenous infusion ude to treat CMV retinitis in patients with AIDS. The recall involved lot number B120217, with an expiration date of May 2015. The drug was recalled because some of the vials contained an unknown particulate. For more information about this recall, please…